Get the Stockscreener App
0.422
3.21%
-0.014
Pre-market:
.41
-0.012
-2.84%
Gelteq Ltd stock is traded at $0.422, with a volume of 9,107.
It is down -3.21% in the last 24 hours and down -42.25% over the past month.
Gelteq Ltd is a clinical and science-based company focused on developing and commercializing white label gel-based delivery solutions for prescription drugs, nutraceuticals, pet care and other products, preserving the simplicity, accessibility, and efficacy of oral delivery. Its principal products are edible gels and their application in gel-based dosage forms across pets, sports, pharmaceutical, over-the-counter, and nutraceutical categories, leveraging its patent pending multiple ingredient dosage forms. The company develops and tests gel-based delivery systems for humans and pets and focuses on out-licensing its technology to companies to create products that can be manufactured and sold, while continuing to manufacture existing products under license on a white label basis.
See More
Previous Close:
$0.436
Open:
$0.4223
24h Volume:
9,107
Relative Volume:
0.13
Market Cap:
$4.52M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-1.1433
EPS:
-0.3691
Net Cash Flow:
-
1W Performance:
-3.17%
1M Performance:
-42.25%
6M Performance:
-52.07%
1Y Performance:
-77.19%
1-Day Range:
$0.41
$0.45
1-Week Range:
$0.387
$0.50
52-Week Range:
$0.387
$3.51
Gelteq Ltd Stock (GELS) Company Profile
Compare GELS vs TAK, HLN, TEVA, ZTS, UTHR
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
GELS
Gelteq Ltd
|
0.422 | 4.67M | 0 | 0 | 0 | -0.3691 |
TAK
Takeda Pharmaceutical Co Adr
|
16.25 | 52.07B | 29.91B | 1.30B | 3.49B | 0.4056 |
HLN
Haleon Plc Adr
|
9.29 | 41.28B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
34.07 | 39.78B | 17.53B | 1.58B | 444.18M | 1.3457 |
ZTS
Zoetis Inc
|
81.32 | 33.57B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
568.43 | 24.02B | 3.17B | 1.29B | 1.01B | 27.09 |
Gelteq Ltd Stock (GELS) Latest News
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
Gelteq begins clinical trial for veterinary antiparasitic drug - Investing.com
Gelteq begins clinical trial for veterinary antiparasitic drug By Investing.com - Investing.com Australia
Gelteq Commences Veterinary Medicine Clinical Trial to Support an FDA Regulatory Pathway - The Manila Times
Gelteq secures up to $3.5M debt financing to support commercialization - MSN
Sommer Ray’s Imaraïs taps Healthy Extracts to make 4M beauty gummies - Stock Titan
TradingKey - TradingKey
Gelteq announces USD $3.5 million strategic debt financing to accelerate commercialization and support revenue growth - marketscreener.com
Gelteq Secures USD $3.5 Million in Debt Financing on May 12, 2026 - geneonline.com
Gelteq secures up to $3.5M debt financing for trials - Investing.com
Gelteq secures up to $3.5M debt financing for trials By Investing.com - Investing.com India
Gelteq Announces USD $3.5 Million Strategic Debt Financing to Accelerate Commercialization and Support Revenue Growth - marketscreener.com
Gelteq lands $3.5M to speed its pharmaceutical and nutraceutical gels - Stock Titan
What makes Gelteq Limited (GELS) a compelling holding for the long term (Hovering) 2026-05-08Trending Entry Points - Newser
What Gelteq Limited (GELS) is doing that smarter investors notice (Institutional Selling) 2026-05-05Social Buzz - Newser
GELS Price Today: Gelteq Limited Stock Price, Quote & Chart | MEXC - MEXC Exchange
GELS (Gelteq Limited) management prioritizes emerging tech vertical investments to drive future sustainable revenue growth.Expert Momentum Signals - Newser
Simon H Szewach Net Worth (2026) - GuruFocus
Bradley Glenn Karp Net Worth (2026) - GuruFocus
Nathan J Givoni Net Worth (2026) - GuruFocus
Paul Michael Wynne Net Worth (2026) - GuruFocus
ETF Watch: Is Gelteq Limited likely to announce a buyback2026 Earnings Surprises & Low Risk High Reward Ideas - baoquankhu1.vn
Market Review: How liquid is Gelteq Limited stockExit Point & Consistent Income Trade Recommendations - baoquankhu1.vn
What support levels matter for Gelteq Limited (GELS) Stock | Price at $0.75, Up 13.12%Trending Momentum Stocks - Newser
Gelteq Ltd (GELS) Cash Flow - TradingKey
Will Gelteq Limited (GELS) Stock Outperform Peers | Price at $0.70, Up 3.09%Stock Analysis Community - Newser
GELS PE Ratio & Valuation, Is GELS Overvalued - Intellectia AI
Five straight record quarters set up Healthy Extracts for a bigger 2026 - Stock Titan
Short Interest in Gelteq Limited Drops 26.3% in March - National Today
Travel Stocks: How does Gelteq Limited compare to its peers2026 Analyst Calls & Safe Capital Growth Stock Tips - baoquankhu1.vn
Gelteq Announces New Product Development Agreement with Melbourne Health for Novel Bowel Polyp Growth Reduction Compound - MSN
Gelteq receives Nasdaq notice for minimum bid price deficiency By Investing.com - za.investing.com
Gelteq receives Nasdaq notice for minimum bid price deficiency - Investing.com
Nasdaq warns Gelteq (NASDAQ: GELS) after shares stay below $1.00 - Stock Titan
Investor Summit Announces Q1 Presenter Line Up (Presentations 3/25, 1-on-1s 3/26) - ChartMill
[Form 3] Gelteq Ltd Initial Statement of Beneficial Ownership - Stock Titan
Gelteq (NASDAQ: GELS) director reports family trust-held positions - Stock Titan
Gelteq Ltd (GELS) officer discloses 500,000 trust-held shares on Form 3 - Stock Titan
Gelteq Ltd (GELS) CEO details indirect share and note holdings - Stock Titan
GELS Earnings History & Surprises | EPS & Revenue Results | GELTEQ LTD (NASDAQ:GELS) - ChartMill
GELS Should I Buy - Intellectia AI
Retail Trends: Will Gelteq Limited outperform small cap indexesTrade Signal Summary & Comprehensive Market Scan Insights - baoquankhu1.vn
Will Gelteq Limited stock hit new highs in YEAR2025 Key Highlights & Growth Focused Entry Reports - mfd.ru
Gelteq and Healthy Extracts to Expand Gel-Based Nutrition Technologies with New Strategic Manufacturing & Commercial Partnership - The Manila Times
IPO Launch: Can Gelteq Limited outperform in the next rallyQuarterly Risk Review & Safe Investment Capital Preservation Plans - baoquankhu1.vn
HUB Cyber Security Receives Compliance Notice from Nasdaq - Intellectia AI
YYAI Director Hongyu Zhou Acquires 4.215M Shares at $1.37, Totaling $5.77M - Intellectia AI
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
Inspire Veterinary Partners Stock Drops Amid Market Weakness - Intellectia AI
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
Gelteq (NASDAQ:GELS) Trading Up 6.9% – What’s Next? - Defense World
Gelteq Ltd Stock (GELS) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.92%
4.44%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):